P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice

The ionotropic ATP-gated P2X7 receptor is an important contributor to inflammatory signaling cascades via the release of Interleukin-1β, as well as having roles in cell death, neuronal plasticity and the release of neurotransmitters. Accordingly, there is interest in targeting the P2X7 receptor for the treatment of epilepsy. However, the signaling pathways downstream of P2X7 receptor activation remain incompletely understood. Notably, recent studies showed that P2X7 receptor expression is controlled, in part, by microRNAs (miRNAs). Here, we explored P2X7 receptor-dependent microRNA expression by comparing microRNA expression profiles of wild-type (wt) and P2X7 receptor knockout mice before and after status epilepticus. Genome-wide microRNA profiling was performed using hippocampi from wt and P2X7 receptor knockout mice following status epilepticus induced by intra-amygdala kainic acid. This revealed that the genetic deletion of the P2X7 receptor results in distinct patterns of microRNA expression. Specifically, we found that in vehicle-injected control mice, the lack of the P2X7 receptor resulted in the up-regulation of 50 microRNAs and down-regulation of 35 microRNAs. Post-status epilepticus, P2X7 receptor deficiency led to the up-regulation of 44 microRNAs while 13 microRNAs were down-regulated. Moreover, there was only limited overlap among identified P2X7 receptor-dependent microRNAs between control conditions and post-status epilepticus, suggesting that the P2X7 receptor regulates the expression of different microRNAs during normal physiology and pathology. Bioinformatic analysis revealed that genes targeted by P2X7 receptor-dependent microRNAs were particularly overrepresented in pathways involved in intracellular signaling, inflammation, and cell death; processes that have been repeatedly associated with P2X7 receptor activation. Moreover, whereas genes involved in signaling pathways and inflammation were common among up- and down-regulated P2X7 receptor-dependent microRNAs during physiological and pathological conditions, genes associated with cell death seemed to be restricted to up-regulated microRNAs during both physiological conditions and post-status epilepticus. Taken together, our results demonstrate that the P2X7 receptor impacts on the expression profile of microRNAs in the brain, thereby possibly contributing to both the maintenance of normal cellular homeostasis and pathological processes.

[1]  Jianzhong Zhang,et al.  miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease. , 2019, Biochemical and biophysical research communications.

[2]  L. Cui,et al.  Cortical Neuron-Derived Exosomal MicroRNA-181c-3p Inhibits Neuroinflammation by Downregulating CXCL1 in Astrocytes of a Rat Model with Ischemic Brain Injury , 2019, Neuroimmunomodulation.

[3]  E. Jimenez-Mateos,et al.  Regulation of P2X7 receptor expression and function in the brain , 2019, Brain Research Bulletin.

[4]  T. Engel,et al.  ATP release during seizures – A critical evaluation of the evidence , 2019, Brain Research Bulletin.

[5]  F. Ortega,et al.  P2 receptor interaction and signalling cascades in neuroprotection , 2019, Brain Research Bulletin.

[6]  Robin Kopp,et al.  P2X7 Interactions and Signaling – Making Head or Tail of It , 2019, Front. Mol. Neurosci..

[7]  J. Prehn,et al.  Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y1 Receptor in Experimental Epilepsy , 2019, The Journal of Neuroscience.

[8]  A. Vezzani,et al.  Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy , 2019, Nature Reviews Neurology.

[9]  R. Biswas,et al.  MicroRNA-155: A Master Regulator of Inflammation. , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  X. Pang,et al.  Role of microRNA‐155 in modifying neuroinflammation and γ‐aminobutyric acid transporters in specific central regions after post‐ischaemic seizures , 2019, Journal of cellular and molecular medicine.

[11]  Yun-wu Zhang,et al.  Silencing MicroRNA-155 Attenuates Kainic Acid-Induced Seizure by Inhibiting Microglia Activation , 2019, Neuroimmunomodulation.

[12]  M. Nieto-Díaz,et al.  MicroRNA‐135a‐5p reduces P2X7‐dependent rise in intracellular calcium and protects against excitotoxicity , 2019, Journal of Neurochemistry.

[13]  Xiaowei Wang,et al.  Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data , 2019, Genome Biology.

[14]  Donncha F. O’Brien,et al.  MicroRNA-22 Controls Aberrant Neurogenesis and Changes in Neuronal Morphology After Status Epilepticus , 2018, Front. Mol. Neurosci..

[15]  H. Hamer,et al.  Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy , 2018, EBioMedicine.

[16]  J. Lucas,et al.  Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus , 2018, Cell Death & Disease.

[17]  A. Gambardella,et al.  Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy , 2018, Molecular therapy. Nucleic acids.

[18]  Xiaoshun He,et al.  Effects of let‐7e on LPS‐Stimulated THP‐1 Cells Assessed by iTRAQ Proteomic Analysis , 2018, Proteomics. Clinical applications.

[19]  C. Stadelmann,et al.  Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody , 2018, eLife.

[20]  L. Watkins,et al.  MicroRNAs: Roles in Regulating Neuroinflammation , 2018, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[21]  T. Engel,et al.  The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy , 2018, Front. Pharmacol..

[22]  A. Köfalvi,et al.  Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation , 2018, Cell Death & Disease.

[23]  R. Dingledine,et al.  Commonalities in epileptogenic processes from different acute brain insults: Do they translate? , 2018, Epilepsia.

[24]  C. Gross,et al.  MicroRNA‐induced silencing in epilepsy: Opportunities and challenges for clinical application , 2018, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  F. Di Virgilio,et al.  The P2X7 receptor: A main player in inflammation , 2017, Biochemical pharmacology.

[26]  Artemis G. Hatzigeorgiou,et al.  DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions , 2017, Nucleic Acids Res..

[27]  Hsien-Da Huang,et al.  miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions , 2017, Nucleic Acids Res..

[28]  Li-Gang Huang,et al.  Silencing rno-miR-155-5p in rat temporal lobe epilepsy model reduces pathophysiological features and cell apoptosis by activating Sestrin-3 , 2017, Brain Research.

[29]  Donncha F. O’Brien,et al.  Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug‐refractory epilepsy , 2017, Epilepsia.

[30]  Dong Zhou,et al.  Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus , 2017, Journal of Molecular Neuroscience.

[31]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[32]  L. Fourgeaud,et al.  The role of microglial P2X7: modulation of cell death and cytokine release , 2017, Journal of Neuroinflammation.

[33]  P. Wlaź,et al.  Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in Mice , 2017, Neurochemical Research.

[34]  G. Boylan,et al.  Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice , 2017, Neuropharmacology.

[35]  Tobias Engel,et al.  The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy , 2017, Front. Neurosci..

[36]  E. Jimenez-Mateos,et al.  A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22. , 2017, Biochimica et biophysica acta. Molecular cell research.

[37]  D. Goldstein,et al.  MicroRNAs in epilepsy: pathophysiology and clinical utility , 2016, The Lancet Neurology.

[38]  M. Kasper,et al.  P2X7R-dependent regulation of glycogen synthase kinase 3β and claudin-18 in alveolar epithelial type I cells of mice lung , 2016, Histochemistry and Cell Biology.

[39]  E. Audinat,et al.  Purinergic signaling in epilepsy , 2016, Journal of neuroscience research.

[40]  M. T. Khan,et al.  Pilocarpine-Induced Status Epilepticus Increases the Sensitivity of P2X7 and P2Y1 Receptors to Nucleotides at Neural Progenitor Cells of the Juvenile Rodent Hippocampus , 2016, Cerebral cortex.

[41]  D. Henshall,et al.  Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models , 2016, PloS one.

[42]  Donncha F. O’Brien,et al.  Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy , 2016, The Journal of Neuroscience.

[43]  S. Dedeurwaerdere,et al.  P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy , 2016, Neuropharmacology.

[44]  D. Henshall,et al.  ATPergic signalling during seizures and epilepsy , 2016, Neuropharmacology.

[45]  W. Cheadle,et al.  Anti‐inflammatory effects of miR‐21 in the macrophage response to peritonitis , 2016, Journal of leukocyte biology.

[46]  Guangchuang Yu,et al.  ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. , 2016, Molecular bioSystems.

[47]  P. Correia‐de‐Sá,et al.  Up‐regulation of P2X7 receptor–mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex , 2016, Epilepsia.

[48]  E. Jimenez-Mateos,et al.  microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus , 2015, Scientific Reports.

[49]  Michael R. Johnson,et al.  MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy – comparison with human epileptic samples , 2015, Scientific Reports.

[50]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[51]  D. Henshall,et al.  P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus , 2015, Epilepsy & Behavior.

[52]  M. Joglekar,et al.  A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy , 2015, Scientific Reports.

[53]  Kyung-Ok Cho,et al.  Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline , 2015, Nature Communications.

[54]  Philippe Ryvlin,et al.  Epilepsy: new advances , 2015, The Lancet.

[55]  M. Ferracin,et al.  The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma , 2015, Oncogene.

[56]  S. Impey,et al.  Profiling status epilepticus-induced changes in hippocampal RNA expression using high-throughput RNA sequencing , 2014, Scientific Reports.

[57]  B. Sperlágh,et al.  P2X7 receptor: an emerging target in central nervous system diseases. , 2014, Trends in pharmacological sciences.

[58]  D. Henshall,et al.  P2X7 Receptor Inhibition Interrupts the Progression of Seizures in Immature Rats and Reduces Hippocampal Damage , 2014, CNS neuroscience & therapeutics.

[59]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[60]  John H. Zhang,et al.  P2X7 Receptor Antagonism Inhibits p38 Mitogen-Activated Protein Kinase Activation and Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats , 2013, Critical care medicine.

[61]  C. Mooney,et al.  Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A‐438079 , 2013, Epilepsia.

[62]  R. Unwin,et al.  The relationship between P2X4 and P2X7: a physiologically important interaction? , 2013, Front. Physiol..

[63]  E. Audinat,et al.  Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus , 2013, Glia.

[64]  R. Gregory,et al.  Argonaute2 expression is post-transcriptionally coupled to microRNA abundance. , 2013, RNA.

[65]  J. Lucas,et al.  Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus. , 2013, Brain : a journal of neurology.

[66]  Donncha F. O’Brien,et al.  CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. , 2013, Brain : a journal of neurology.

[67]  Donncha F. O’Brien,et al.  Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects , 2012, Nature Medicine.

[68]  Donncha F. O’Brien,et al.  Reduced Mature MicroRNA Levels in Association with Dicer Loss in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis , 2012, PloS one.

[69]  D. Henshall,et al.  Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  D. Górecki,et al.  Expression, assembly and function of novel C‐terminal truncated variants of the mouse P2X7 receptor: re‐evaluation of P2X7 knockouts , 2012, British journal of pharmacology.

[71]  Ji-Eun Kim,et al.  P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-α-mediated pathway in the rat hippocampus following status epilepticus , 2011, Journal of Neuroinflammation.

[72]  Ji-Eun Kim,et al.  The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. , 2011, The Journal of clinical investigation.

[73]  J. Prehn,et al.  Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  E. Jimenez-Mateos,et al.  Seizure preconditioning and epileptic tolerance: models and mechanisms. , 2009, International journal of physiology, pathophysiology and pharmacology.

[75]  C. Reid,et al.  The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore , 2009, The Journal of Neuroscience.

[76]  H. Ulrich,et al.  Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine , 2009, Epilepsy Research.

[77]  J. Lucas,et al.  Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons , 2008, Journal of Cell Science.

[78]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[79]  E. Audinat,et al.  Status Epilepticus Induces a Particular Microglial Activation State Characterized by Enhanced Purinergic Signaling , 2008, The Journal of Neuroscience.

[80]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[81]  Amaia M. Arranz,et al.  P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis , 2007, The Journal of Neuroscience.

[82]  E. Lynd-Balta,et al.  P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain , 2006, Brain Research.

[83]  Á. Simonyi,et al.  P2X7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons , 2005, Purinergic Signalling.

[84]  Maryann E Martone,et al.  Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain‐dependent manner , 2005, Journal of neurochemistry.

[85]  F. Di Virgilio,et al.  P2X7 receptor: Death or life? , 2005, Purinergic Signalling.

[86]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[87]  R. Simon,et al.  Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse , 2002, Journal of neuroscience research.

[88]  J. Deuchars,et al.  Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus , 2002, Journal of neurochemistry.

[89]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[90]  E. Kawashima,et al.  Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.

[91]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[92]  R. Case,et al.  What Is Epilepsy? , 2020, A Practical Guide to Supporting People with Epilepsy.

[93]  G. Burnstock.  Introduction to Purinergic Signalling in the Brain. , 2020, Advances in experimental medicine and biology.

[94]  J. Xing,et al.  Inhibition of microRNA-155 alleviates neurological deficits following transient global ischemia and contribution of neuroinflammation and oxidative stress in the hippocampus. , 2019, Current pharmaceutical design.

[95]  D. O’Carroll,et al.  General Principals of miRNA Biogenesis and Regulation in the Brain , 2013, Neuropsychopharmacology.

[96]  G. Hannon,et al.  Small RNA sorting: matchmaking for Argonautes , 2011, Nature Reviews Genetics.

[97]  毛利 元信.  Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice , 2010 .

[98]  Anjali Arondekar,et al.  Abundance , 2000, Peach State.

[99]  R. Unwin,et al.  The relationship between P 2 X 4 and P 2 X 7 : a physiologically important interaction ? , 2022 .